BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Isu Abxis Co. Ltd.

Headquarters: Seongnam, South Korea
Year Founded: 2001
Status: Public
Industry Sector: HealthTechnology
CEO: Yup Hwang, MBA
Number Of Employees: 190
Enterprise Value: $130,312,580
PE Ratio: 6.41
Exchange/Ticker 1: KOSDAQ:086890
Exchange/Ticker 2: N/A
Latest Market Cap: $149,850,351

BioCentury | Jun 4, 2022
Product Development

New modalities give HER3 another shot at ASCO

ASCO data from Daiichi, Merus show anti-HER3 efficacy in challenging indications
BioCentury | Jun 22, 2018
Clinical News

Antibodies neutralize Catalyst's Factor IX variant

BioCentury | Sep 19, 2016
Company News

Catalyst Biosciences hematology news

BioCentury | Apr 6, 2015
Company News

Catalyst Biosciences, Targacept deal

BioCentury | Oct 14, 2013
Company News

Catalyst Biosciences, Isu Abxis deal

BioCentury | Oct 14, 2013
Finance

Highlights of weekly biotech stock moves

Regulatory, clinical and other milestones
Items per page:
1 - 8 of 8
Help Center
Username
Request Training
Submit Data Correction
Ask a Question